Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 11, 2000, Pages 983-989

  Zemaitaitis, Magdalena O ^a   Lee, John M ^a   Troncoso, Juan C ^b   Muma, Nancy A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Cross linking; Neurodegeneration; Progressive supranuclear palsy (PSP); Tau; Tauopathy; Transglutaminase

Indexed keywords

ANTIBODY; LYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANTIBODY AFFINITY; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOLECULAR STABILITY; NEUROFIBRILLARY TANGLE; OCCIPITAL CORTEX; PAIRED HELICAL FILAMENT; PATHOGENESIS; PONS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN PURIFICATION;

EID: 0033764710     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.11.983     Document Type: Article

References (47)

1. Progressive supranuclear palsy
2. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata
3. Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity
4. Prevalence and natural history of progressive supranuclear palsy
5. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
6. Cortical degeneration in progressive supranuclear palsy. A comparison with corticobasal ganglionic degeneration
7. Glial inclusions in CNS degenerative diseases
8. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging
9. Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophillic, tau-positive astrocytes in progressive supranuclear palsy
10. Tau-positive glial inclusions in PSP, CBD, and Pick's disease
11. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau
12. Studies on the expression of the microtubule associated protein tau during mouse brain development with newly isolated complementary DNA probes
13. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2
14. Tau protein and the neurofibrillary pathology of Alzheimer's disease
15. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
16. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
17. Developmentally regulated expression of specific tau seqences
18. Tau protein binds to microtubules through a flexible array of distributed weak sites
19. Pathological tau proteins in postencephalitic parkinsonism: Comparison with Alzheimer's disease and other neurodegenerative disorders
20. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
21. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
22. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
23. Free fatty acids stimulate the polymerization of tau and amyloid β peptides: In vitro evidence for a common effector of pathogenesis in alzheimer's disease
24. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
25. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulfated glycosaminoglycans
26. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration
27. Localization of transglutaminase in hippocampal neurons-implications for alzheimer's disease
28. Transglutaminase activity is increase in Alzheimer's disease brain
29. Possible roles of transglutaminase in Alzheimer's disease
30. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease
31. Cellular transglutaminases in neural development
32. The ε-(g-glutamyl)lysine crosslink and the catalytic role of transglutaminases
33. Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers
34. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau
35. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures
36. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)
37. A comparative study of modified Bielschowsky, Bodian and thiflavin S stains of Alzheimer's neurofibrillary tangles
38. Transglutaminase activity and N (glutamyl)lysine isopeptide levels during cell growth: An enzymic and immunological study
39. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD
40. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degradation in Alzheimer's disease
41. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to huntington hippocampus
42. Effects of microtuble stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons
43. Biochemical events in naturally occurring forms of cell death
44. Calcium-dependent transglutaminase of rat sympathetic ganglion in development and nerve injury
45. Changes in cytoskeletal proteins in the rat facial nucleus following axotomy
46. Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant
47. Abnormal tau phosphorylation at Ser-396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding